Cisco raises annual revenue forecast as AI boom boosts networking gear demand

Immuron Limited (IMC) is a biopharmaceutical company in Australia. IMC's product ranges target infectious diseases of the gastrointestinal tract, chronic diseases such as fatty liver (NASH), and prevention of influenza. IMC currently has one product in the market and seven products under research and development process. http://www.immuron.com Source link

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Aptos”,sans-serif; mso-ascii-font-family:Aptos; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Aptos; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual;} June S&P E-mini futures: High volatility, panic conditions still prevail. The odds favor continuation up to 5700-50…